Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.

Authors

A B Bigley
K Rezvani
N Shah
T Sekine
N Balneger
M Pistillo
N Agha
H Kunz
D P O'Connor
C M Bollard, George Washington UniversityFollow
R J Simpson

Document Type

Journal Article

Publication Date

8-1-2016

Journal

Clinical and Experimental Immunology

Volume

185

Issue

2

Inclusive Pages

239-51

DOI

10.1111/cei.12785

Keywords

Adolescent; Adult; Antigens, CD57; Cell Line, Tumor; Cytomegalovirus; Cytomegalovirus Infections; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Female; Healthy Volunteers; Histocompatibility Antigens Class I; Humans; K562 Cells; Killer Cells, Natural; Lymphocyte Activation; Lymphoma; Male; Middle Aged; Multiple Myeloma; NK Cell Lectin-Like Receptor Subfamily C; Virus Latency; Young Adult

APA Citation

Bigley, A., Rezvani, K., Shah, N., Sekine, T., Balneger, N., Pistillo, M., Agha, N., Kunz, H., O'Connor, D., Bollard, C., & Simpson, R. (2016). Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.. Clinical and Experimental Immunology, 185 (2). http://dx.doi.org/10.1111/cei.12785

Peer Reviewed

1